ASHG 2019
Recent articles
Antidote to ‘poison’ DNA may treat lethal form of epilepsy
An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.
Antidote to ‘poison’ DNA may treat lethal form of epilepsy
An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.
Brain ‘organoids’ point to new drug target for fragile X syndrome
New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.
Brain ‘organoids’ point to new drug target for fragile X syndrome
New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.
Massive project doubles list of genes tied to autism
The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.
Massive project doubles list of genes tied to autism
The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.
Explore more from The Transmitter
Early experience reshapes zebrafish retinal cells, alters behavior
The cells undergo a classic form of plasticity previously thought to occur only in downstream visual circuits.
Early experience reshapes zebrafish retinal cells, alters behavior
The cells undergo a classic form of plasticity previously thought to occur only in downstream visual circuits.
Loss of interneuron plasticity may be shared hallmark of neurodevelopmental conditions
Restoring an experience-dependent interneuron plasticity gene in adulthood improves memory and cuts seizures in CNTNAP2 knockout mice, a new study shows.
Loss of interneuron plasticity may be shared hallmark of neurodevelopmental conditions
Restoring an experience-dependent interneuron plasticity gene in adulthood improves memory and cuts seizures in CNTNAP2 knockout mice, a new study shows.
Neuropsychiatric MRI brain signatures fail reproducibility test
Small neuroimaging studies are unlikely to capture consistent anatomical changes related to conditions such as autism, schizophrenia and mood disorders, according to a new “wake-up call” study.
Neuropsychiatric MRI brain signatures fail reproducibility test
Small neuroimaging studies are unlikely to capture consistent anatomical changes related to conditions such as autism, schizophrenia and mood disorders, according to a new “wake-up call” study.